货号 | 物种 | 产品描述 | 蛋白结构 | 纯度 | 活性 |
---|---|---|---|---|---|
B73-H52E2 |
![]() Human |
Human B7-H3 / CD276 Protein, His Tag |
![]() |
||
B73-H5253 |
![]() Human |
Human B7-H3 / CD276 Protein, Fc Tag |
![]() |
||
B73-M5255 |
![]() Mouse |
Mouse B7-H3 / CD276 Protein, Fc Tag |
![]() |
||
B73-M52H4 |
![]() Mouse |
Mouse B7-H3 / CD276 Protein, His Tag |
![]() |
||
B73-H82E6 |
![]() Human |
Biotinylated Human B7-H3 / CD276 Protein, Avitag,His Tag |
![]() |
||
B73-H82F5 |
![]() Human |
Biotinylated Human B7-H3 / CD276 Protein, Fc,Avitag |
![]() |
||
B73-C52Ha |
![]() Cynomolgus |
Cynomolgus B7-H3 / CD276 Protein, His Tag |
![]() |
英文名称 | 研发代码 | 研发阶段 | 公司 | 适应症 | 临床试验 |
---|---|---|---|---|---|
Monoclonal antibody 8H9 I-131 | 131-I-8H9; 8H9-MAb; 131I-8H9-(B7-H3) | 临床三期 | 斯隆-凯特琳癌症中心, Y-mAbs | 成神经细胞瘤 | 详情 |
DS-5573 | DS-5573; DS-5573a | 临床一期 | 第一三共 | 实体瘤 | 详情 |
4SCAR-276 | 4SCAR-276 | 临床二期 | 深圳市免疫基因治疗研究院 | 实体瘤 | 详情 |
Enoblituzumab | MGA-271,MGA271 | 临床二期 | MacroGenics | 前列腺癌 | 详情 |
SCRI-CARB7H3 | SCRI-CARB7H3,SCRICARB7H3 | 临床一期 | Seattle Children's Hospital | 神经胶质瘤, 中枢神经肿瘤 | 详情 |
Monoclonal antibody 8H9 I-124 | 124I-8H9; 124I-8H9-(B7-H3) | 临床二期 | 斯隆-凯特琳癌症中心, Weill Cornell Medical College | 神经胶质瘤 | 详情 |
MGC-018 | MGC-018 | 临床二期 | MacroGenics | 实体瘤 | |
B7-H3 CAR-T cell therapy (Zhejiang University) | 临床二期 | 浙江大学 | 成胶质细胞瘤 | 详情 | |
DS-7300 | DS-7300 | 临床二期 | 第一三共, Sarah Cannon Research Institute | 实体瘤 | 详情 |
Orlotamab | MGD-009; B7-H3 x CD3 | 临床一期 | MacroGenics | 实体瘤 | 详情 |